Scientific Sessions
  • #AHA22
  • Virtual Experience Access
  • Sessions Posters
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Featured Exhibitors
  • Program
  • Previews
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Featured Exhibitors
  • Program
  • Previews
Resources
  • #AHA22
  • Virtual Experience Access
  • Sessions Posters
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter iconFacebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 12th, 2021

Leslie A. Leinwand, PhD, receives the 2021 Eugene Braunwald Academic Mentorship Award


Leslie A. Leinwand, PhD
Leslie A. Leinwand, PhD

Leslie A. Leinwand, PhD, of the University of Colorado Boulder, was presented with the 2021 Eugene Braunwald Academic Mentorship Award. She is chief scientific officer of the BioFrontiers Institute, and a distinguished professor of molecular, cellular and developmental biology at the University of Colorado Boulder, professor of cardiology at the University of Colorado School of Medicine and Howard Hughes Medical Institute professor. Her contributions have revolutionized our understanding of heart failure by using molecular techniques in heart and muscle biology. She was selected as this year’s recipient of the Eugene Braunwald Academic Mentorship Award because of her instrumental role in mentoring young cardiovascular scientists and physician scientists. 

Throughout her career, she has been passionate about science education and advancement, she encourages pure scientific discovery, and she fosters career development, which she emphasizes through mentorships. She has provided invaluable support and guidance to scientists and researchers including her active mentees, as well as her previous students, many of whom remain in contact with her as their career-long mentor.  

“It is such an honor to receive this award in the name of Eugene Braunwald and to follow all of the previous outstanding awardees,” said Dr. Leinwand. “Mentoring is one of the most important things that we do as scientists, and I am tremendously proud of all of my trainees who have gone onto such distinguished careers and become great mentors themselves.” 

Dr. Leinwand earned her doctorate in biology from Yale University. She has mentored nearly 200 cardiovascular and physician scientists during the past 40 years. Many of her protégés are current cardiovascular leaders who hold the title of chief of cardiology, some have been internationally recognized for leading-edge research. In 2017, she was recognized with the Association’s Distinguished Scientist Award for outstanding contributions to the field of heart health. Dr. Leinwand holds four U.S. patents for the solubilization of protein after bacterial expression using sarkosyl, transgenic model for heart failure, diagnosis and treatment of myocardial failure, and methods and compositions for inducing physiological hypertrophy, with another three patents pending. She has published more than 320 scientific papers in peer-reviewed journals.  

The Leinwand Lab at the University of Colorado’s College of Arts and Sciences, founded and led by Dr. Leinwand, is focused on genetics and molecular physiology of inherited diseases of the heart, as well as how biological sex and diet affect the heart. The scientists use multidisciplinary approaches, including molecular biology, analysis of human tissues and mouse genetics and cardiac physiology. They study cardiac and skeletal muscle with particular focus on the genetic diseases that affect them. They also are exploring extreme biology exhibited by the Burmese python after consuming infrequent and massive meals. 

Interesting Stories
New Double Take Videos from NEJM
Sponsored by NEJM Group
New Double Take Videos from NEJM
MiCare Path joins the AHA CHTI and will integrate AHA science-based
Sponsored by MiCare Path
MiCare Path joins the AHA CHTI and will integrate AHA science-based
Data-driven precision medicine
Sponsored by Tempus
Data-driven precision medicine
Modern Wearable Defibrillation
Sponsored by Kestra Medical Technologies
Modern Wearable Defibrillation
More Content
Screenshot 2021 11 02 130142
Sponsored Content
Antiplatelet Therapy in Patients With Coronary Artery Disease and Acute Ischemic Stroke/Transient Ischemic Attack
Oct 4th, 2022
Getty Images 1180201381
Daily Coverage
Join the Scientific Sessions 2022 Scavenger Hunt
Aug 15th, 2022
Live Meeting Image
AHA21
Member Connect
Dec 13th, 2021
P104 Steven Botts Image
AHA21
Members Connect: ERG Governs Chromatin Accessibility in Aortic Endothelial Cells
Dec 13th, 2021
Pres Address Lloyd Jones2
AHA21
Watch: #AHA21 recap and look ahead
Nov 22nd, 2021
Getty Images 1301907602
AHA21
Mark your calendar for #AHA22
Nov 19th, 2021
Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
Nov 19th, 2021
Lbs02 Group Blood Patel
AHA21
Update on local and global hypertension science
Nov 19th, 2021
Getty Images 1219980553 61849bc953192
AHA21
Read all about #AHA21 in your daily coverage
Nov 16th, 2021
(from left to right): Brahmajee K. Nallamothu, MD, MPH, FAHA, Rhoda Au, PhD, Seth Martin, MD, MHS, FAHA, and Andrea Beaton, MD, FAHA
AHA21
QCOR at Sessions: mHealth strategies could help treat CVD around the world
Nov 15th, 2021
(from left to right, top to bottom rows): Corey E. Ventetuolo, MD, MS, Magdi Yacoub, OM, FRS, Karen Joynt Maddox, MD, MPH, FAHA, Gregory Lewis, MD, Marco Guazzi, MD, PhD, FAHA, Ana Macumbi, MD, PhD, FESC, Mark T. Gladwin, MD, FAHA, and William Bain, MD
AHA21
The shifting profile of cardiopulmonary COVID-19 survivors
Nov 15th, 2021
(from left to right): Jonathan P. Piccini, MD, MHS, FAHA, and Steven A. Lubitz, MD, MPH, FAHA
AHA21
Late-Breaking Science: New information in cardiac disease
Nov 15th, 2021